Safety and efficacy of the Essential Pro paclitaxel drug-coated balloon in de novo coronary lesions
REC: interventional cardiology (English Edition) · 13.08.2026
DOI: 10.24875/recice.m26000601 ↗Kurz gefasst
Fachartikel in der Zeitschrift REC: interventional cardiology (English Edition), online erschienen am 13.08.2026. Verfasst von Lucio Padilla und 15 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Padilla, L., Liberman, F., Tello, J., Rosas, P., Feder, J., Piaggio, I., Spaletra, P., Pedernera, G., Mascolo, P., Ordoñez, S., Santilli, P., Candiello, A., Cura, F., Belardi, J., and, & Lamelas, P. (2026). Safety and efficacy of the Essential Pro paclitaxel drug-coated balloon in de novo coronary lesions. REC: interventional cardiology (English Edition). https://doi.org/10.24875/recice.m26000601
Vancouver
Padilla L, Liberman F, Tello J, Rosas P, Feder J, Piaggio I, et al. Safety and efficacy of the Essential Pro paclitaxel drug-coated balloon in de novo coronary lesions. REC: interventional cardiology (English Edition). 2026. doi:10.24875/recice.m26000601
BibTeX
@article{Padilla2026,
author = {Padilla, Lucio and Liberman, Federico and Tello, Jorge and Rosas, Pablo and Feder, Julián and Piaggio, Ignacio and Spaletra, Pablo and Pedernera, Gustavo and Mascolo, Pablo and Ordoñez, Santiago and Santilli, Pablo and Candiello, Alfonsina and Cura, Fernando and Belardi, Jorge and and and Lamelas, Pablo},
title = {Safety and efficacy of the Essential Pro paclitaxel drug-coated balloon in de novo coronary lesions},
journal = {REC: interventional cardiology (English Edition)},
year = {2026},
doi = {10.24875/recice.m26000601}
}
EUVIMED